Join the Vortioxetine group to help and get support from people like you.
Vortioxetine News
Brintellix (vortioxetine) Renamed Trintellix (vortioxetine) in U.S. to Avoid Name Confusion
Deerfield, Ill., and Osaka, Japan (May 2, 2016) – Takeda Pharmaceuticals U.S.A., Inc., a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502) (collectively “Takeda”), and Lundb...
FDA Medwatch Alert: Brintellix (vortioxetine): Drug Safety Communication - Brand Name Change to Trintellix, to Avoid Confusion With Antiplatelet Drug Brilinta (ticagrelor)
ISSUE: FDA has approved a brand name change for the antidepressant Brintellix (vortioxetine) to decrease the risk of prescribing and dispensing errors resulting from name confusion with the ...
FDA Medwatch Alert: Brintellix (vortioxetine) and Brilinta (ticagrelor): Drug Safety Communication - Name Confusion
ISSUE: FDA is warning health care professionals and patients that reports of confusion between the antidepressant Brintellix and anti-blood clotting medication Brilinta have resulted in the wrong...